V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001672 | 230000861 | 1.64 | 84.8 | Adjuvant (A) | 2016-07-17 | 2017-01-07 | Paclitaxel 7 day | N | N | 230005755 | FLUOROURACIL |
| 230001673 | 230001593 | 1.59 | null | Palliative (P) | null | 2018-01-30 | Oxaliplatin + Modified de Gramont | N | null | 230005912 | CETUXIMAB + OXALIPLATIN + MDG |
| 230001674 | 230000873 | 1.73 | 90.6 | null | 2015-10-08 | 2015-10-28 | Capecitabine + Oxaliplatin 21day | 02 | Y | 230007118 | CAPECITABINE + OXALIPLATIN |
| 230001675 | 230000876 | null | 73.3 | Curative (C) | 2015-02-26 | 2015-03-01 | CAPECITABINE + OXALIPLATIN | N | N | 230007151 | CABOZANTINIB |
| 230001676 | 230000878 | 1.54 | 81 | Palliative (P) | 2017-03-11 | 2017-03-12 | Carboplatin + Etoposide iv&po | 02 | N | 230007216 | SORAFENIB |
| 230001677 | 230000886 | 1.7 | null | Palliative (P) | 2019-02-08 | 2019-02-08 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 230007554 | FLUOROURACIL + MITOMYCIN + RT |
| 230001678 | 230000891 | 1.64 | 85.9 | Palliative (P) | 2018-03-05 | 2018-03-11 | CETUXIMAB + MDG | N | null | 230007563 | IRINOTECAN + MDG |
| 230001679 | 230000892 | 0 | 61.3 | Not known (9) | 2016-07-16 | 2016-07-16 | Rituximab (Maintenance) | N | N | 230007606 | CISPLATIN + RT |
| 230001680 | 230000900 | null | null | Palliative (P) | 2017-09-11 | 2017-09-19 | Oxaliplatin + Modified de Gramont | 02 | null | 230008316 | BEVACIZUMAB + FLUOROURACIL |
| 230001681 | 230000907 | 1.64 | 72.1 | Adjuvant (A) | 2015-05-18 | 2018-08-05 | Capecitabine + Oxaliplatin 21day | N | N | 230008421 | DOCETAXEL |
| 230001682 | 230000913 | 1.81 | 90.6 | Palliative (P) | 2018-06-11 | 2018-07-16 | Rituximab (Maintenance) | N | N | 230009139 | TRIFLURIDINE + TIPIRACIL |
| 230001683 | 230000919 | 1.65 | 105.6 | Palliative (P) | 2014-12-26 | 2014-12-26 | ETOPOSIDE | 02 | N | 230009647 | SORAFENIB |
| 230001684 | 230000926 | 1.63 | 57.75 | Palliative (P) | 2015-12-18 | 2016-04-21 | null | 02 | null | 230010381 | FLUOROURACIL |
| 230001685 | 230000931 | 1.85 | 121.2 | null | 2017-02-23 | 2017-03-10 | Capecitabine + Oxaliplatin 14day | 2 | N | 230011482 | CVP R |
| 230001686 | 230000938 | 1.74 | 51.6 | Palliative (P) | 2017-09-23 | 2017-09-23 | Trastuzumab Subcutaneous | 02 | N | 230012015 | RITUXIMAB |
| 230001687 | 230000970 | null | 64 | Palliative (P) | 2017-06-18 | 2017-06-23 | Fluorouricil + Folonic Acid (MdG) | 02 | null | 230015009 | IBRUTINIB |
| 230001688 | 230000976 | 1.77 | 84.2 | Palliative (P) | 2012-02-15 | 2015-01-13 | Capecitabine + Oxaliplatin 21day | N | Y | 230016462 | IPILIMUMAB |
| 230001689 | 230000984 | 1.54 | 50.8 | Palliative (P) | 2019-04-24 | 2019-07-18 | AFLIBERCEPT + FU + IRINOTECAN | 02 | N | 230019072 | DOCETAXEL + NINTEDANIB |
| 230001690 | 230000989 | 1.69 | 92 | Adjuvant (A) | 2018-06-25 | 2018-07-13 | Capecitabine 42days + RT | 02 | N | 230020468 | TRABECTEDIN |
| 230001691 | 230000992 | 1.63 | 73.3 | null | 2019-06-03 | 2019-06-04 | FEC 100 | N | null | 230021656 | NOT MATCHED |
| 230001692 | 230001001 | 1.59 | 134 | Curative (C) | 2018-04-16 | 2018-09-24 | LEAM | 2 | N | 230023578 | CARBOPLATIN + PACLITAXEL |
| 230001693 | 230001013 | 1.49 | null | Neo-adjuvant (N) | 2018-05-09 | 2018-05-09 | LEAM | 02 | N | 230025262 | CARBOPLATIN |
| 230001694 | 230001427 | 1.72 | 92.9 | Palliative (P) | 2018-11-04 | 2018-11-27 | Capecitabine + Oxaliplatin 21day | N | N | 230025405 | CAPECITABINE + OXALIPLATIN |
| 230001695 | 230001024 | 1.69 | null | Palliative (P) | 2016-03-19 | 2016-03-22 | Capecitabine | 2 | N | 230027082 | RITUXIMAB |
| 230001696 | 230001031 | 1.85 | 76.3 | Palliative (P) | 2017-10-20 | 2017-11-08 | BEVACIZUMAB + FLUOROURACIL | 2 | N | 230001447 | METHOTREXATE HIGH DOSE |
| 230001697 | 230001045 | null | 86.9 | Palliative (P) | 2019-06-27 | 2019-06-27 | LENALIDOMIDE | N | N | 230012425 | ERLOTINIB |
| 230001698 | 230000632 | 1.73 | 61.3 | Palliative (P) | 2019-02-03 | 2019-02-06 | Irinotecan + Modified De Gramont | 02 | N | 230015009 | CAPECITABINE + OXALIPLATIN |
| 230001699 | 230001303 | 1.59 | null | Palliative (P) | 2016-10-01 | 2017-04-10 | Irinotecan + Modified De Gramont | N | N | 230021348 | OXALIPLATIN + MDG |
| 230001700 | 230000675 | 1.57 | 87.5 | Palliative (P) | 2020-01-03 | 2020-01-16 | Erlotinib | N | N | 230022180 | CETUXIMAB + IRINOTECAN + MDG |
| 230001701 | 230000681 | 1.6 | 62.7 | Palliative (P) | 2015-11-10 | 2016-06-09 | Capecitabine | N | null | 230022891 | IRINOTECAN + MDG + PANITUMUMAB |
| 230001702 | 230000684 | 1.69 | 44 | Palliative (P) | 2014-05-03 | 2014-06-12 | Capecitabine | N | N | 230023028 | AFLIBERCEPT + FU + IRINOTECAN |
| 230001703 | 230001312 | 1.53 | 96.5 | Palliative (P) | 2018-08-07 | 2018-09-03 | GEFITINIB | N | N | 230024143 | CETUXIMAB + IRINOTECAN + MDG |
| 230001704 | 230000714 | 1.64 | 63 | Palliative (P) | 2017-06-09 | 2017-06-09 | AFLIBERCEPT + FU + IRINOTECAN | 02 | N | 230026262 | TRIFLURIDINE + TIPIRACIL |
| 230001705 | 230001323 | 1.63 | null | Palliative (P) | 2014-10-10 | 2015-01-02 | PCV | 2 | N | 230026784 | OXALIPLATIN + MDG |
| 230001706 | 230000720 | 1.54 | 71 | Adjuvant (A) | 2015-06-25 | 2016-01-27 | Methotrexate High Dose (3g/m2) | N | N | 230026784 | CAPECITABINE + OXALIPLATIN |
| 230001707 | 230000731 | 1.88 | 72.05 | Curative (C) | 2016-05-16 | 2016-05-16 | CRIZOTINIB | N | N | 230000436 | IRINOTECAN |
| 230001708 | 230000752 | 1.75 | 89.5 | Curative (C) | 2014-10-16 | 2016-08-25 | Trifluridine + Tipiracil | 02 | N | 230000981 | CAPECITABINE + OXALIPLATIN |
| 230001709 | 230000762 | 1.75 | 62 | Palliative (P) | 2016-08-27 | 2016-08-27 | VANDETANIB | N | N | 230001490 | IRINOTECAN |
| 230001710 | 230001351 | 1.7 | 95.4 | Palliative (P) | 2019-01-17 | 2019-02-08 | R GCVP | N | N | 230002819 | OXALIPLATIN + MDG |
| 230001711 | 230000819 | 1.64 | 74.3 | Palliative (P) | 2019-03-05 | 2020-01-21 | Capecitabine + Oxaliplatin 21day | N | N | 230003846 | FLUOROURACIL |
| 230001712 | 230000846 | 1.63 | 57.6 | Curative (C) | 2016-07-03 | 2016-08-01 | Trastuzumab 21 day maintenance | N | N | 230005256 | SORAFENIB |
| 230001713 | 230000854 | 1.62 | 72.4 | Palliative (P) | 2018-12-20 | 2018-12-23 | GEFITINIB | N | N | 230005457 | ENZALUTAMIDE |
| 230001714 | 230000874 | 1.65 | 94 | null | 2017-08-06 | 2017-08-28 | Capecitabine + Oxaliplatin 14day | 02 | N | 230007118 | OXALIPLATIN + MDG |
| 230001715 | 230000887 | 1.61 | 70.3 | Adjuvant (A) | 2019-05-01 | 2019-05-01 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | 230007554 | TRASTUZUMAB |
| 230001716 | 230000892 | 1.7 | 72 | Not known (9) | 2016-07-15 | 2016-07-16 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 230007606 | IRINOTECAN + MDG |
| 230001717 | 230001389 | 1.83 | null | Palliative (P) | 2017-10-08 | 2017-10-17 | CAPECITABINE + TEMOZOLOMIDE | 02 | Y | 230008316 | IRINOTECAN + MDG |
| 230001718 | 230001393 | 1.69 | 76 | Palliative (P) | 2017-06-16 | 2018-08-05 | Irinotecan + Modified De Gramont | N | N | 230008421 | CVP R |
| 230001719 | 230000914 | 1.71 | 83 | Palliative (P) | 2014-08-04 | 2018-07-16 | R GCVP | N | N | 230009139 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 230001720 | 230000920 | 1.64 | 93.6 | Adjuvant (A) | 2014-12-26 | 2014-12-26 | AFLIBERCEPT + FU + IRINOTECAN | 02 | N | 230009647 | DOCETAXEL |
| 230001721 | 230000927 | 1.59 | null | Palliative (P) | 2010-07-23 | 2016-12-07 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 230010381 | TRASTUZUMAB |